Manufacturers should have issued a Cartiva recall after discovering high failure rates with the toe implant, according to allegations being prepared for trial.
Manufacturer failed to issue a Cartiva SCI recall even after receiving nearly 150 reports of implant failures and device loosening, according to the lawsuit.
The Cartiva big toe implant's polyvinyl membrane construction is prone to shrinkage, loosening and deformation, the lawsuit claims.
A Texas man blames the Cartiva implant failure on a lack of adequate testing by the manufacturers, who he says hid the device's failings from the public.
More than a quarter of Cartiva toe implant recipients expressed dissatisfaction with the procedure, with less than 40% reporting being satisfied with the results.
Cartiva SCI manufacturers knew about the high rates of complications linked to the big toe implant, but failed to warn the medical community or patients, according to the complaint.
Fusion of her big toe left plaintiff with decreased flexibility, and the Cartiva implant lawsuit indicates she will need additional reconstructive surgery.
Lawsuits allege design problems with Cartiva toe implants cause complications after surgery, often resulting in additional procedures, loss of mobility and worse long-term outcomes for big toe pain.
Michigan appeals court determined plaintiff's expert witness presented sufficient evidence to allow a jury to consider the the Cartiva implant malpractice lawsuit
Plaintiffs each dismissed their lawsuits shortly after they were filed, raising speculation that the manufacturer may have reached Cartiva toe implant settlements or agreed to a tolling agreement to extend the statute of limitations
